AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ninoi, T.
Right arrow Articles by Inoue, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ninoi, T.
Right arrow Articles by Inoue, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

TIPS Versus Transcatheter Sclerotherapy for Gastric Varices

Teruhisa Ninoi1, Kenji Nakamura1, Toshio Kaminou2, Norifumi Nishida1, Yukimasa Sakai1, Toshiaki Kitayama1, Masao Hamuro1, Ryusaku Yamada1, Tetsuo Arakawa3 and Yuichi Inoue1

1 Department of Radiology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
2 Department of Radiology, Faculty of Medicine, Tottori University, Tottori, Japan.
3 Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.



View larger version (44K):

[in a new window]
 
Fig. 1A. Illustrations of transcatheter sclerotherapy. Drawings illustrate balloon-occluded retrograde transvenous obliteration (A) and percutaneous transhepatic sclerotherapy (B). EOI = ethanolamine oleate with iopamidol.

 


View larger version (39K):

[in a new window]
 
Fig. 1B. Illustrations of transcatheter sclerotherapy. Drawings illustrate balloon-occluded retrograde transvenous obliteration (A) and percutaneous transhepatic sclerotherapy (B). EOI = ethanolamine oleate with iopamidol.

 


View larger version (10K):

[in a new window]
 
Fig. 2A. Comparison of transjugular intrahepatic portosystemic shunt (TIPS, dotted lines) and transcatheter sclerotherapy (TS, solid lines) groups for cumulative bleeding using Kaplan-Meier method and log-rank test. Table beneath figure shows number of patients at risk in each group. Columns correspond to number of years on graph. Graphs and tables show results for gastric (p = 0.0003, A), esophageal (p = 0.5956, B) and all p = 0.0015, C) variceal bleeding.

 


View larger version (10K):

[in a new window]
 
Fig. 2B. Comparison of transjugular intrahepatic portosystemic shunt (TIPS, dotted lines) and transcatheter sclerotherapy (TS, solid lines) groups for cumulative bleeding using Kaplan-Meier method and log-rank test. Table beneath figure shows number of patients at risk in each group. Columns correspond to number of years on graph. Graphs and tables show results for gastric (p = 0.0003, A), esophageal (p = 0.5956, B) and all p = 0.0015, C) variceal bleeding.

 


View larger version (11K):

[in a new window]
 
Fig. 2C. Comparison of transjugular intrahepatic portosystemic shunt (TIPS, dotted lines) and transcatheter sclerotherapy (TS, solid lines) groups for cumulative bleeding using Kaplan-Meier method and log-rank test. Table beneath figure shows number of patients at risk in each group. Columns correspond to number of years on graph. Graphs and tables show results for gastric (p = 0.0003, A), esophageal (p = 0.5956, B) and all p = 0.0015, C) variceal bleeding.

 


View larger version (11K):

[in a new window]
 
Fig. 3A. Comparison of transjugular intrahepatic portosystemic shunt (TIPS, dotted lines) and transcatheter sclerotherapy (TS, solid lines) groups for cumulative survival using Kaplan-Meier method and log rank test. Table beneath figure shows number of patients at risk in each group. Columns correspond to number of years on graph. Graphs and tables show cumulative survival results overall (p = 0.0048, A), for Child-Pugh class A (p = 0.0033, B), and for Child-Pugh classes B and C (p = 0.4277, C).

 


View larger version (10K):

[in a new window]
 
Fig. 3B. Comparison of transjugular intrahepatic portosystemic shunt (TIPS, dotted lines) and transcatheter sclerotherapy (TS, solid lines) groups for cumulative survival using Kaplan-Meier method and log rank test. Table beneath figure shows number of patients at risk in each group. Columns correspond to number of years on graph. Graphs and tables show cumulative survival results overall (p = 0.0048, A), for Child-Pugh class A (p = 0.0033, B), and for Child-Pugh classes B and C (p = 0.4277, C).

 


View larger version (11K):

[in a new window]
 
Fig. 3C. Comparison of transjugular intrahepatic portosystemic shunt (TIPS, dotted lines) and transcatheter sclerotherapy (TS, solid lines) groups for cumulative survival using Kaplan-Meier method and log rank test. Table beneath figure shows number of patients at risk in each group. Columns correspond to number of years on graph. Graphs and tables show cumulative survival results overall (p = 0.0048, A), for Child-Pugh class A (p = 0.0033, B), and for Child-Pugh classes B and C (p = 0.4277, C).

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Roentgen Ray Society.